30 Leading Fill Finish Manufacturing Companies Shaping Innovation and Market Growth to 2031

Discover the top 30 companies driving innovation in the fill finish manufacturing market. This in-depth analysis explores competitive advantages, transformative trends, and key players shaping aseptic drug filling, sterile pharmaceutical packaging, and injectable manufacturing through 2031. Access the comprehensive market research report for further insights into this evolving industry.

Spotlights on the Industry's Top Fill Finish Manufacturing Companies

The fill finish manufacturing market is evolving as pharmaceutical and biotechnology companies expand production of vaccines, biologics, cell and gene therapies, and other injectable medicines. Growing demand for sterile drug products is encouraging investment in automated filling lines, ready-to-use containers, prefilled syringes, cartridges, and advanced vial systems. Manufacturers are prioritizing aseptic processing, contamination control, flexible production formats, and improved inspection and traceability. Integrated equipment, single-use technologies, and digital process monitoring are also influencing equipment selection and facility design. Competition spans primary packaging suppliers, filling-line manufacturers, sterilization specialists, and companies offering integrated solutions for regulated pharmaceutical production.

1. West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is a provider of injectable drug administration and containment solutions, with products used in pharmaceutical fill finish operations. Its portfolio includes elastomeric closures, vial stoppers, seals, and components for injectable delivery systems. These products help drug manufacturers address container-closure integrity, compatibility, and product protection requirements. West also offers containment and delivery solutions designed for complex medicines, including biologics. Its relevance to fill finish manufacturing lies in supplying critical components that support sterile packaging and reliable delivery of injectable therapies.

2. Becton, Dickinson and Company

Becton, Dickinson and Company (BD) participates in the fill finish ecosystem through drug containment and delivery systems, including prefillable syringes and associated pharmaceutical packaging technologies. These solutions are used by pharmaceutical manufacturers developing injectable medicines and biologics. BD's capabilities in medical technology, materials, and drug delivery support the industry's move toward ready-to-use formats and patient-friendly administration. Its role is particularly relevant where filling operations must align with syringe performance, product compatibility, and container-closure requirements. BD's broader global manufacturing presence supports pharmaceutical customers across multiple therapeutic areas.

3. Syntegon Technology GmbH

Syntegon Technology GmbH develops processing and packaging equipment for the pharmaceutical industry, including solutions for aseptic filling and closing of vials, syringes, and cartridges. Its technologies support sterile liquid and other pharmaceutical product formats, with equipment configurations designed for different production capacities and automation requirements. Syntegon's portfolio can incorporate filling, stoppering, capping, and integrated line technologies to help manufacturers manage process consistency and contamination risks. Its relevance to the market is grounded in pharmaceutical machinery engineering and systems designed for regulated manufacturing environments.

4. IMA S.p.A.

IMA S.p.A. supplies processing and packaging machinery for pharmaceutical manufacturing, including equipment for filling and packaging sterile products. Through its pharmaceutical machinery operations, the company serves manufacturers seeking automated solutions for vials, syringes, cartridges, and other pharmaceutical formats. Its technologies can support different batch sizes and production requirements, from specialized applications to higher-throughput lines. IMA's engineering and automation capabilities are relevant to manufacturers working to improve line efficiency, format flexibility, and process integration. Its broader pharmaceutical equipment portfolio also enables coordination with upstream and downstream production stages.

5. Stevanato Group S.p.A.

Stevanato Group S.p.A. provides pharmaceutical glass containers, drug containment solutions, and equipment and services for injectable drug manufacturing. Its portfolio includes vials, cartridges, and syringes, alongside technologies supporting inspection, assembly, and fill finish operations. The company serves pharmaceutical and biotechnology manufacturers that require packaging systems designed for sensitive injectable products. Its combination of primary packaging and machinery expertise is relevant to integrated production strategies, particularly as demand grows for biologics and other complex medicines. Stevanato Group's capabilities span multiple stages of the pharmaceutical packaging value chain.

6. Gerresheimer AG

Gerresheimer AG develops primary packaging and drug delivery solutions for pharmaceutical and biotechnology companies. Its product range includes glass and plastic containers, vials, cartridges, and syringes used in injectable drug packaging. These components support fill finish operations by providing packaging formats designed for product protection, compatibility, and delivery. Gerresheimer's industrial expertise in pharmaceutical glass and plastic manufacturing is relevant to manufacturers seeking dependable container supply and packaging formats for a range of injectable therapies. Its position across pharmaceutical packaging and drug delivery makes it an important participant in the broader fill finish ecosystem.

7. AptarGroup, Inc.

AptarGroup, Inc. develops drug delivery systems and dispensing technologies, including components used in pharmaceutical packaging. Its healthcare business supports drug manufacturers with delivery solutions designed for product performance, usability, and protection. In the fill finish value chain, Aptar's relevance is primarily connected to drug delivery and packaging components rather than complete high-speed filling lines. Its expertise in engineered dispensing systems and packaging technologies can support pharmaceutical companies developing differentiated delivery formats. The company's role should be considered alongside other suppliers of primary packaging and drug administration components.

8. Dätwyler Holding Inc.

Dätwyler Holding Inc. supplies high-quality elastomer components for healthcare and pharmaceutical applications, including closures and sealing solutions used in injectable drug packaging. These components are important in fill finish manufacturing because they help maintain container-closure integrity and protect sterile products during storage and distribution. The company's materials and component engineering capabilities are relevant to pharmaceutical manufacturers with demanding requirements for cleanliness, consistency, and compatibility. Dätwyler participates in the market primarily as a component supplier, complementing filling equipment manufacturers and providers of vials, syringes, and other primary packaging formats.

9. Danaher Corporation

Danaher Corporation participates in pharmaceutical manufacturing through a portfolio of life sciences and biotechnology businesses that support bioprocessing, analytical testing, and production workflows. Its relevance to fill finish manufacturing is mainly through technologies and capabilities that help pharmaceutical manufacturers develop, monitor, and control processes around drug production. Depending on the application, its businesses can support quality testing, process characterization, and biopharmaceutical manufacturing operations. Danaher is not solely a fill finish equipment provider; its broader life sciences and bioprocessing presence makes it relevant to the manufacturing ecosystem surrounding sterile drug production.

10. OPTIMA

OPTIMA develops filling, packaging, and production systems for pharmaceutical and other regulated industries. Its pharmaceutical technologies support applications involving sterile liquids and other sensitive products, with equipment designed around filling accuracy, process control, and production-line integration. Depending on the configuration, systems can incorporate filling, closing, handling, and inspection-related stages. OPTIMA's engineering focus is relevant to manufacturers seeking automated solutions that can accommodate different container formats and stringent cleanliness requirements. Its role in the fill finish market centers on machinery and integrated production equipment rather than primary packaging materials.

11. Bausch+Ströbel

Bausch+Ströbel specializes in machinery for pharmaceutical filling and packaging, with solutions for vials, syringes, cartridges, and ampoules. Its equipment portfolio supports processes such as filling, stoppering, sealing, and handling within pharmaceutical production lines. The company serves manufacturers that require precise dosing, reliable process performance, and equipment compatible with regulated sterile manufacturing environments. Its expertise in pharmaceutical machinery is relevant to both specialized production and automated manufacturing operations. Bausch+Ströbel's focus on fill and finish processes positions it as a direct equipment supplier in the market.

12. Groninger & Co. GmbH

Groninger & Co. GmbH develops filling and closing systems for the pharmaceutical, healthcare, and consumer goods industries. Its pharmaceutical equipment supports the processing of vials, syringes, cartridges, and other containers used for liquid and sensitive products. Solutions are designed to address dosing precision, product handling, automation, and line integration. Groninger's focus on filling and closing technologies makes it relevant to manufacturers seeking flexible equipment for changing production needs and packaging formats. Its machinery can form part of broader fill finish lines serving pharmaceutical and biotechnology production.

13. SGD Pharma

SGD Pharma manufactures pharmaceutical glass packaging, including vials used to contain injectable drugs and other medicines. Its glass container expertise supports pharmaceutical manufacturers that need packaging designed for product protection, dimensional consistency, and compatibility with filling and sealing operations. The company is relevant to fill finish manufacturing because container quality and performance influence filling-line operation, inspection, and the integrity of the final packaged product. SGD Pharma's position is primarily in primary packaging rather than filling machinery, making it a complementary supplier within the sterile pharmaceutical production chain.

14. SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA supplies drug containment solutions, including pharmaceutical glass vials, ampoules, cartridges, and prefillable syringe systems. Its products are used by pharmaceutical and biotechnology companies packaging injectable medicines, including sensitive formulations that require carefully engineered primary containers. SCHOTT Pharma's materials and manufacturing expertise supports container quality, compatibility, and reliable performance during filling and storage. Its broad portfolio makes it relevant to manufacturers evaluating ready-to-use packaging and other formats that can streamline production preparation and support sterile fill finish processes.

15. Nipro Corporation

Nipro Corporation operates in medical devices and pharmaceutical packaging, including glass containers and drug delivery products used in healthcare applications. Its pharmaceutical packaging activities support the containment of injectable medicines and other products requiring reliable primary packaging. These offerings are relevant to fill finish operations because vial and related container performance can affect filling efficiency, sealing, inspection, and product protection. Nipro's manufacturing experience across healthcare products gives it a role in the broader injectable drug supply chain. Its contribution is primarily associated with packaging and delivery components rather than complete filling-line systems.

16. Bausch Advanced Technology Group

Bausch Advanced Technology Group provides equipment and engineering solutions for pharmaceutical and medical manufacturing applications. Its relevance to fill finish manufacturing is associated with specialized machinery and automation used in production and packaging processes. Pharmaceutical equipment projects typically require attention to process requirements, product handling, and integration with a facility's broader manufacturing system. Buyers should assess the group's specific equipment offering and current portfolio when comparing it with dedicated aseptic filling-line suppliers. Its inclusion reflects the role of specialized machinery providers in supporting pharmaceutical production operations.

17. Maquinaria Industrial Dara, S.L.

Maquinaria Industrial Dara, S.L. develops filling and packaging machinery for pharmaceutical and related industries. Its equipment portfolio is associated with filling and closing applications for containers used in regulated product manufacturing. For fill finish operations, machinery suppliers such as Dara can support production requirements involving dosing, container handling, and integration into packaging lines. The company's relevance depends on the particular equipment configuration and the application being evaluated. Pharmaceutical manufacturers should review specifications, automation features, format flexibility, and compliance requirements to determine suitability for a given sterile production process.

18. Steriline S.r.l.

Steriline S.r.l. specializes in machinery and integrated lines for aseptic processing and pharmaceutical packaging. Its solutions include equipment for filling and closing containers such as vials, syringes, and cartridges, as well as systems designed to support sterile manufacturing workflows. The company's capabilities are relevant to pharmaceutical producers investing in contamination control, automation, and production-line integration. Steriline's focus on aseptic pharmaceutical equipment positions it as a direct participant in fill finish manufacturing, particularly for facilities seeking equipment configurations tailored to their product formats and production requirements.

19. Automated Systems of Tacoma, LLC

Automated Systems of Tacoma, LLC provides automation and manufacturing equipment solutions. Its relevance to pharmaceutical fill finish operations should be assessed against the company's specific equipment portfolio and the requirements of the application. Automation providers can contribute to production workflows through engineered systems, handling equipment, or customized machinery, but not every solution is designed for aseptic pharmaceutical filling. Before treating the company as a direct competitor in sterile fill finish equipment, readers should verify its current pharmaceutical offerings, validated applications, and ability to meet the relevant cleanroom and regulatory requirements.

20. Weiler Engineering, Inc.

Weiler Engineering, Inc. is known for blow-fill-seal technology, which forms a container, fills it with product, and seals it within an integrated automated process. This approach is used for selected pharmaceutical and healthcare products where container formation and filling can be combined in a controlled system. The technology can reduce manual handling and support efficient production of suitable liquid products. Weiler's specialized equipment makes it relevant to fill finish manufacturing, particularly for manufacturers evaluating blow-fill-seal as an alternative to conventional container supply and separate filling operations.

21. Fedegari Autoclavi S.p.A.

Fedegari Autoclavi S.p.A. develops sterilization and contamination-control equipment for pharmaceutical and life sciences manufacturing. Its portfolio includes autoclaves and systems used in sterilization processes that support sterile production environments. While sterilization equipment is distinct from filling machinery, it is an important part of the broader fill finish workflow, helping manufacturers process equipment, components, and materials according to validated procedures. Fedegari's relevance lies in supporting the sterilization and aseptic processing requirements surrounding pharmaceutical filling, rather than serving as a supplier of complete filling lines alone.

22. Shandong Pharmaceutical Glass

Shandong Pharmaceutical Glass is a pharmaceutical glass packaging manufacturer associated with containers used for medicines, including glass products serving injectable drug packaging applications. Such packaging is an important input for fill finish operations, where container dimensions, strength, quality, and compatibility with filling and sealing equipment influence production performance. The company's relevance is primarily as a supplier of pharmaceutical glass containers rather than an integrated filling-equipment provider. Specific product grades, export availability, and suitability for particular injectable formulations should be confirmed against current technical documentation and customer requirements.

23. Mitsubishi Gas Chemical

Mitsubishi Gas Chemical operates across chemicals and advanced materials, with technologies that may support pharmaceutical packaging and related applications. Its inclusion in the fill finish market should be evaluated in relation to the specific materials or packaging technologies supplied for pharmaceutical use. The company is not generally identified as a manufacturer of complete aseptic filling lines, so its relevance may be indirect or product-specific. For an accurate competitive assessment, its current pharmaceutical packaging portfolio and direct involvement in injectable drug containment should be verified before assigning it a defined position in this market.

24. Terumo Corporation

Terumo Corporation is a medical technology company with products and capabilities spanning medical devices, blood management, and pharmaceutical-related solutions. Its role in the fill finish ecosystem is linked to injectable drug delivery and associated container or device technologies, depending on the product category. Such systems can be important when pharmaceutical products are packaged in syringes or other delivery formats that must meet demanding performance and quality requirements. Terumo's broader healthcare manufacturing expertise makes it relevant to the injectable product value chain, although its exact role should be distinguished from suppliers of filling-line machinery.

25. SKAN AG

SKAN AG specializes in equipment and systems for aseptic processing, including isolator technology used to provide controlled environments for pharmaceutical manufacturing. Isolators can support fill finish operations by helping protect products and processes from contamination and by enabling controlled handling during sterile filling. The company's capabilities are relevant to pharmaceutical manufacturers implementing containment strategies, automated operations, and stringent environmental controls. SKAN's contribution is primarily in aseptic infrastructure and process protection, complementing filling and closing equipment in integrated sterile manufacturing lines.

26. ATS Life Science Systems

ATS Life Science Systems provides automation and manufacturing solutions for life sciences applications. Its relevance to pharmaceutical production can include engineered automation, assembly, and process systems designed around product-specific requirements. In the fill finish context, its exact role depends on the system and application, since general life sciences automation is not necessarily equivalent to validated aseptic filling technology. Pharmaceutical manufacturers considering the company should verify its current fill finish capabilities, sterile processing experience, and compliance support. It is best evaluated as a potential automation and systems integration participant where its documented offering matches the application.

27. Corning Inc.

Corning Inc. develops specialty glass, materials, and technologies serving scientific, industrial, and life sciences markets. Its pharmaceutical packaging relevance includes glass technologies and related innovations intended to support drug containment and manufacturing needs. Glass properties are important in fill finish operations because packaging must be compatible with the drug product and withstand filling, sealing, handling, and storage. Corning's materials science capabilities make it relevant to the development of advanced pharmaceutical container solutions. Its role should be differentiated from companies whose primary business is manufacturing complete filling and closing machinery.

28. Credence MedSystems

Credence MedSystems develops drug delivery systems, including syringe-based technologies designed to support the administration of injectable medicines. Its relevance to fill finish manufacturing is associated with specialized delivery-device formats and the packaging requirements needed to prepare products for downstream use. Device design can influence component selection, filling compatibility, assembly, and product handling. Credence is therefore best understood as a drug delivery technology participant within the wider injectable medicine ecosystem, rather than a supplier of conventional high-speed fill finish lines. Specific platform requirements should be assessed for each pharmaceutical application.

29. 3P Innovation Ltd.

3P Innovation Ltd. provides engineering, automation, and manufacturing solutions for regulated industries, including pharmaceutical and medical device applications. Its capabilities may include bespoke machinery and automated production systems developed to address specialized process requirements. In the fill finish market, its relevance depends on the specific equipment and validated applications it offers for pharmaceutical filling, handling, or associated production steps. Manufacturers evaluating 3P Innovation should confirm whether its current portfolio directly supports aseptic filling and the required regulatory environment. Its potential contribution is in tailored automation and engineering for complex manufacturing needs.

30. Colanar AG

Colanar AG develops filling and packaging machinery for pharmaceutical and other industries, with solutions for handling and filling liquid products into different container formats. Its equipment can support production requirements involving dosing accuracy, controlled product handling, and integration into packaging workflows. For pharmaceutical applications, the specific system design and configuration determine its suitability for sterile fill finish operations. Colanar's role in the market is associated with filling machinery and customized equipment solutions, and manufacturers should assess the available configurations against their process, validation, and regulatory requirements.